melatonin has been researched along with olmesartan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Adamcová, M; Arendášová, K; Aziriová, S; Bárta, A; Celec, P; Hrenák, J; Kamodyová, N; Krajčírovičová, K; Paulis, L; Rajkovičová, R; Repová, K; Simko, F | 1 |
2 other study(ies) available for melatonin and olmesartan
| Article | Year |
|---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Protective effect of captopril, olmesartan, melatonin and compound 21 on doxorubicin-induced nephrotoxicity in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Doxorubicin; Glomerular Filtration Rate; Imidazoles; Male; Melatonin; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 2; Renal Agents; Renal Insufficiency, Chronic; Tetrazoles; Treatment Outcome | 2013 |